Mechanistic rationales for targeting interleukin-17A in spondyloarthritis

19:00 EST 7 Mar 2017 | Arthritis Research and Therapy

The term spondyloarthritis (SpA) is used to describe a group of inflammatory autoimmune diseases, including ankylosing spondylitis and psoriatic arthritis, with common genetic risk factors and clinical feature...

Original Article: Mechanistic rationales for targeting interleukin-17A in spondyloarthritis


More From BioPortfolio on "Mechanistic rationales for targeting interleukin-17A in spondyloarthritis"

Quick Search


Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....